These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31478182)

  • 1. Vitamin D supplementation ameliorates severity of generalized anxiety disorder (GAD).
    Eid A; Khoja S; AlGhamdi S; Alsufiani H; Alzeben F; Alhejaili N; Tayeb HO; Tarazi FI
    Metab Brain Dis; 2019 Dec; 34(6):1781-1786. PubMed ID: 31478182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder.
    Shen Z; Zhu J; Yuan Y; Ren L; Qian M; Lin M; Cai M; Zhang Z; Shen X
    Psychiatry Res; 2019 Jan; 271():319-324. PubMed ID: 30529313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of inflammatory biomarkers and vitamins in hospitalized patients with SARS-CoV-2 infection and post-COVID syndrome.
    Krčmová LK; Javorská L; Matoušová K; Šmahel P; Skála M; Kopecký M; Suwanvecho C; Přívratská N; Turoňová D; Melichar B
    Clin Chem Lab Med; 2024 May; 62(6):1217-1227. PubMed ID: 38374668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
    Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder.
    Mukherjee D; Krishnamurthy VB; Millett CE; Reider A; Can A; Groer M; Fuchs D; Postolache TT; Saunders EFH
    Bipolar Disord; 2018 Feb; 20(1):27-34. PubMed ID: 28833866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.
    Keefe JR; Mao JJ; Soeller I; Li QS; Amsterdam JD
    Phytomedicine; 2016 Dec; 23(14):1699-1705. PubMed ID: 27912871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: a 28-day, open-label study.
    Mathew SJ; Garakani A; Reinhard JF; Oshana S; Donahue S
    Clin Ther; 2008 Sep; 30(9):1658-66. PubMed ID: 18840371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Vitamin D-K-Calcium Co-Supplementation on Endocrine, Inflammation, and Oxidative Stress Biomarkers in Vitamin D-Deficient Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Razavi M; Jamilian M; Karamali M; Bahmani F; Aghadavod E; Asemi Z
    Horm Metab Res; 2016 Jul; 48(7):446-51. PubMed ID: 27050252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice.
    Ruiz MA; Álvarez E; Carrasco JL; Olivares JM; Pérez M; Rejas J
    Drug Des Devel Ther; 2015; 9():4329-40. PubMed ID: 26273194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of B-vitamins and vitamin D therapy in improving depressive and anxiety disorders: a systematic review of randomized controlled trials.
    Borges-Vieira JG; Cardoso CKS
    Nutr Neurosci; 2023 Mar; 26(3):187-207. PubMed ID: 35156551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D is a potential antidepressant in psychiatric outpatients
.
    Abdul-Razzak KK; Almanasrah SO; Obeidat BA; Khasawneh AG
    Int J Clin Pharmacol Ther; 2018 Dec; 56(12):585-596. PubMed ID: 30336806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Basis Underlying the Therapeutic Potential of Vitamin D for the Treatment of Depression and Anxiety.
    Kouba BR; Camargo A; Gil-Mohapel J; Rodrigues ALS
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 25-hydroxyvitamin D and mental health in young Australian women: Results from the Safe-D study.
    Callegari ET; Reavley N; Gorelik A; Garland SM; Wark JD;
    J Affect Disord; 2017 Dec; 224():48-55. PubMed ID: 27810275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder.
    Woelk H; Schläfke S
    Phytomedicine; 2010 Feb; 17(2):94-9. PubMed ID: 19962288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS.
    Irani M; Minkoff H; Seifer DB; Merhi Z
    J Clin Endocrinol Metab; 2014 May; 99(5):E886-90. PubMed ID: 24606102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group cognitive behavioral therapy targeting intolerance of uncertainty: a randomized trial for older Chinese adults with generalized anxiety disorder.
    Hui C; Zhihui Y
    Aging Ment Health; 2017 Dec; 21(12):1294-1302. PubMed ID: 27592635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
    Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
    Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP
    Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.